Vanberra Signal

RxPriceIndex

Curated by Signal

European pharmaceutical pricing database

Overview

The Rx Price Index is a European pharmaceutical pricing database developed by Black Swan Analysis for use by healthcare professional and the pharmaceutical industry. This web-based database contains the latest product information and pricing for over 320,000 prescription products across Europe and Switzerland. The Rx Price Index is a pool of information that could enable pharmaceutical companies to more effectively set prices for their new prescription products. It gives the user insight into the price levels by pack size and formulation for competing pharmaceutical products in their therapeutic class, and it allows them to see in which countries these products are available. The data from all the countries is sourced from publically available published databases that list medicinal and healthcare products. Subscription based revenue model.

Key facts

Founded
2007

More on Vanberra Signal

Members only
  • Artificial intelligence based marketing campaign management solution provider

    Enterprise Software & InfrastructureGloucester, United Kingdom
  • AI and cloud-based text to video creation platform for professionals

    Enterprise Software & InfrastructureLondon, United Kingdom
  • Road inspection data and digital twin provider

    Enterprise Software & InfrastructureLancaster, United Kingdom

About RxPriceIndex

What does RxPriceIndex do?

The Rx Price Index is a European pharmaceutical pricing database developed by Black Swan Analysis for use by healthcare professional and the pharmaceutical industry.

Where is RxPriceIndex headquartered?

RxPriceIndex is headquartered in Maidenhead, United Kingdom.

When was RxPriceIndex founded?

RxPriceIndex was founded in 2007.

Which sector is RxPriceIndex in?

RxPriceIndex operates in Enterprise Software & Infrastructure.

Who are RxPriceIndex's competitors?

Companies similar to RxPriceIndex include Mediawide, Imaginario, and Gaist Holdings.